Reduced-dose ipilimumab with standard-dose pembrolizumab: is less more?
Overview
publication date
- July 17, 2017
published in
- The Lancet. Oncology Journal
Research
keywords
- Antibodies, Monoclonal, Humanized
- Ipilimumab
Identity
Scopus Document Identifier
- 85024495782
Digital Object Identifier (DOI)
- 10.1016/S1470-2045(17)30518-1
PubMed ID
- 28729152
Additional Document Info
has global citation frequency
volume
- 18
issue
- 9